Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants

Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants

US Patent 6492148 · Granted Dec 10, 2002

Estimated economic value: $1,416,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Attenuated IBV with extended cell culture and tissue tropism2025
Immunogenic composition against avian influenza virus H5 subtype2024
Immunogenic compositions and vaccines comprising African swine fever virus pepti2024
H52 IBV vaccine with heterologous spike protein2023
Immunogenic compositions and vaccines comprising African swine fever virus pepti2023
Vaccine against infectious bronchitis virus2021
Vaccine for runting-stunting syndrome2014
Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epit2008
Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epit2008
Recombinant birnavirus vaccine2006
Method for generating birnavirus from synthetic RNA transcripts2003
Genetically engineered cell culture adapted infectious bursal diseases virus (IB2003